Jecko Thachil: Interrupting Antiplatelet Therapy for Urgent and Planned Surgery
Jecko Thachil, MAHSC Professor, at the University of Manchester, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Cardiovascular and cerebrovascular diseases are major causes of morbidity and morality in the world. Antiplatetelet therapies play a major role in the management of these conditions.
But when a patient receiving antiplatelet medications requires urgent or planned surgery, how do we deal with interrupting these treatments? Discussed in the following review.”
Title: How to undertake procedures while on antiplatelet agents: a hematologist’s view
Authors: Dawn Swan, Robert Turner, James Douketis, Jecko Thachil
Read the Full Article on RPTH.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF